FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Mar 24, 2017
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on March 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4c466432-2f25-4b99-9681-7be32d5278d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1007875
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 820.90(a)Nonconforming product control
- 21 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2024 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| November 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| August 18, 2017 | Not classified | New York District Office |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1282260 - 2025-07-30
- FDA Inspection 1250019 - 2024-09-09
- FDA Inspection 1110911 - 2019-11-25
- FDA Inspection 1042701 - 2018-02-23
- FDA Inspection 1042383 - 2017-08-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.